Divergent synthesis of a pochonin library targeting HSP90 and in vivo efficacy of an identified inhibitor

被引：48

作者：

Barluenga, Sofia ^{[1
]}

Wang, Cuihua ^{[1
]}

Fontaine, Jean-Gonzague ^{[1
]}

Aouadi, Kaiss ^{[1
]}

Beebe, Kristin ^{[2
]}

Tsutsumi, Shinji ^{[2
]}

Neckers, Len ^{[2
]}

Winssinger, Nicolas ^{[1
]}

机构：

[1] Univ Strasbourg 1, Inst Sci & Ingn Supramol, F-67000 Strasbourg, France

[2] NCI, Urol Oncol Branch, Bethesda, MD 20892 USA

来源：

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2008年 / 47卷 / 23期

关键词：

antitumor agents; bioorganic chemistry; natural products; solid-phase synthesis; synthesis design;

D O I：

10.1002/anie.200800233

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

(Chemical Equation Presented) Make a clean breast of it: The generation of a library of pochonin Dderivatives by a solid-phase approach has led to the discovery of pochoxime (see scheme), a potent inhibitor of the heat-shock protein 90, with over 100-fold improved incellular activity. Pochoxime was found to be effective in breast tumor xenografts, leading to a reduction in the tumor size. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

页码：4432 / 4435

页数：4

共 37 条

[1] Halohydrin and oxime derivatives of radicicol: Synthesis and antitumor activities [J].

Agatsuma, T ;

Ogawa, H ;

Akasaka, K ;

Asai, A ;

Yamashita, Y ;

Mizukami, T ;

Akinaga, S ;

Saitoh, Y .

BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (11) :3445-3454

[2] Pharmacological prevention of Parkinson disease in Drosophila [J].

Auluck, PK ;

Bonini, NM .

NATURE MEDICINE, 2002, 8 (11) :1185-1186

[3] Solution- and solid-phase synthesis of radicicol (monorden) and pochonin C [J].

Barluenga, S ;

Moulin, E ;

Lopez, P ;

Winssinger, N .

CHEMISTRY-A EUROPEAN JOURNAL, 2005, 11 (17) :4935-4952

[4] Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2 [J].

Basso, AD ;

Solit, DB ;

Munster, PN ;

Rosen, N .

ONCOGENE, 2002, 21 (08) :1159-1166

[5] A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells [J].

Chiosis, G ;

Timaul, MN ;

Lucas, B ;

Munster, PN ;

Zheng, FF ;

Sepp-Lorenzino, L ;

Rosen, N .

CHEMISTRY & BIOLOGY, 2001, 8 (03) :289-299

[6] Tumor selectivity of Hsp90 inhibitors: The explanation remains elusive [J].

Chiosis, Gabriela ;

Neckers, Len .

ACS CHEMICAL BIOLOGY, 2006, 1 (05) :279-284

[7]

Chiosis G, 2006, CURR OPIN INVEST DR, V7, P534

[8] Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design [J].

Dymock, BW ;

Barril, X ;

Brough, PA ;

Cansfield, JE ;

Massey, A ;

McDonald, E ;

Hubbard, RE ;

Surgenor, A ;

Roughley, SD ;

Webb, P ;

Workman, P ;

Wright, L ;

Drysdale, MJ .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (13) :4212-4215

[9] A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analogues [J].

Gooljarsingh, Lata T. ;

Fernandes, Christine ;

Yan, Kang ;

Zhang, Hong ;

Grooms, Michael ;

Johanson, Kyung ;

Sinnamon, Robert H. ;

Kirkpatrick, Robert B. ;

Kerrigan, John ;

Lewis, Tia ;

Arnone, Marc ;

King, Alastair J. ;

Lai, Zhihong ;

Copeland, Robert A. ;

Tummino, Peter J. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (20) :7625-7630

[10] BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90 [J].

Gorre, ME ;

Ellwood-Yen, K ;

Chiosis, G ;

Rosen, N ;

Sawyers, CL .

BLOOD, 2002, 100 (08) :3041-3044

← 1 2 3 4 →